Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor - Wikidata - awgldk - TriplyDB

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

http://www.wikidata.org/entity/Q24294731

about

A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist Interleukin 1 receptor antagonist. A new member of the interleukin 1 family Osteoimmunology: interactions of the bone and immune system Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation Production of interleukin-1 receptor antagonist by human articular chondrocytes.Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients Refined crystal structure of the interleukin-1 receptor antagonist. Presence of a disulfide link and a cis-proline Solution structure of human interleukin-1 receptor antagonist protein Regulation of serum amyloid A protein expression during the acute-phase response Early immune responses accompanying human asymptomatic Ebola infections HIV-1 coat protein gp120 stimulates interleukin-1beta secretion from human neuroblastoma cells: evidence for a role in the mechanism of cell death The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism Central endothelin ET(B) receptors mediate IL-1-dependent fever induced by preformed pyrogenic factor and corticotropin-releasing factor in the rat Interleukin 1 signaling occurs exclusively via the type I receptor Anti-inflammatory properties of a novel peptide interleukin 1 receptor antagonist Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA.Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.alpha(2)-macroglobulin and alpha(1)-inhibitor-3 mRNA expression in the rat liver after slow interleukin-1 stimulation Mycobacterium leprae actively modulates the cytokine response in naive human monocytes.Cytokines and reproduction Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis.Gut lavage IgG and interleukin 1 receptor antagonist:interleukin 1 beta ratio as markers of intestinal inflammation in children with inflammatory bowel disease.Soluble cytokine receptors: basic immunology and clinical applications.Cytokines in asthma.Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals Requirements for leukocyte adhesion molecules in nephrotoxic nephritis.IRAK1BP1 inhibits inflammation by promoting nuclear translocation of NF-kappaB p50.Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.Age-dependent levels of select immunological mediators in sera of healthy children The neuroimmune-endocrine axis: pathophysiological implications for the central nervous system cytokines and hypothalamus-pituitary-adrenal hormone dynamics.IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis.Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats.Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis.Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

P2860

3aaf60396419a2eb0f8c5d8beb586956f67121fd d6ef6feacf1b7b4bce48fe06c075bb92a3ed1d2b

P248

Q24309431-06FE3234-E9EE-4809-BE52-34A99CF8C9C7 Q24310224-1B17F136-9F8E-4921-B3DF-A2A35161169E Q24321369-C1EBB85D-2368-48E7-9732-C93D62A52A69 Q24563274-A9D9DFD2-12C2-4FCA-873F-F50CA8DDBC79 Q24630432-77941379-B3EA-4446-B970-6DE113B89E48 Q24655113-3CA9C791-EE98-4103-9282-DBDDBBB30CB0 Q24673428-94B2B5F3-60CD-4BD8-99A6-6CF2A6D24A1F Q24807339-9EE3A23E-EA40-42D1-A132-F00DA38BD8F8 Q26823898-863BD67F-11DE-4500-81F8-4708689A80D3 Q27730381-58D1A4D5-4AEB-43AB-BCB6-771FB42D9E87 Q27730839-0246B28E-AA70-42B7-8646-B6218FD54BB1 Q28281545-C822EECF-80FF-4469-BC20-0EC793872B20 Q28344889-F222DBB9-5264-48DF-BBD0-30B23A59796B Q28363800-F14DB61F-81BB-4486-9482-839AB4F4088D Q28569481-74F2F2BD-F13A-4730-B272-E59790708F75 Q28571336-2D88EBC9-AE59-4709-9405-C1F201A77D40 Q28583837-D6883604-2F64-468E-954C-35DCD2F6BD36 Q28611151-00D3B8F6-E820-42BB-B602-D3394A3E4F9C Q28659160-1B18CF87-3941-49D0-983E-E2AB478FEE3A Q30422592-0F3C0925-70E5-4E88-9967-F6A6BD2568AE Q30453928-098AF6FC-27D8-41DE-B36A-34F9DFABE873 Q30476283-B913C644-AADD-4447-8D50-C7F89D8FC824 Q33334088-9B49DEE8-BD7A-4E17-94D1-E0C4BE6F52A0 Q33557846-1908B2DE-1398-41A6-B454-A89C05F72BD4 Q33607792-3CF21888-A043-4220-9E8B-5DD5C675B40E Q33618092-562A6819-6BF7-4DCA-8E5B-50D356664105 Q33618279-878263E1-B455-402E-B0DF-A2BB2F652B08 Q33688222-995547B6-CC77-440C-82FF-1B30DCA381BC Q33717312-7D59A82A-F3D7-47CC-BD93-826589A80B35 Q33798590-7570BC64-BD8C-4A36-8BF3-99B50B90B9F8 Q33890510-54C6D4C2-C846-4CF0-913A-3A06F44FE24C Q33952993-0DDF2C1A-D65D-4FA8-BACB-82BE7924BE2E Q33971359-B6716554-CB2A-43B6-A9EF-DCC50AB7126E Q33992976-6833D839-EC77-4AD7-877A-12968EF7F994 Q34044609-F6CFCAE4-75A1-439E-A270-43905CB2FDD2 Q34074678-A8E9743C-CC92-4C75-A54C-022C8B577094 Q34143196-05BF08E0-124E-4FEF-9E44-0A9EBD1D69B9 Q34192949-9EDA8C45-198F-4504-9B9F-4A7BE6A133C5 Q34236293-E52DA5F1-E3EF-4166-90EF-07889F9D00DA Q34251859-DB75C00E-0900-4C7B-AEED-6F39BEBFF7B4

P2860

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

http://www.wikidata.org/entity/Q24294731

description

1990 nî lūn-bûn

@nan

1990 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@ast

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en-gb

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@nl

type

label

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@ast

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en-gb

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@nl

prefLabel

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@ast

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en-gb

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@nl

P1433

Q24294731-B2610760-42E3-496E-9A52-675476A78316

P1476

Q24294731-2A974139-4B01-47D1-899E-2529B412A7A9

P2093

Q24294731-1A00DC31-D49B-48A0-8652-568D4BBFD271

Q24294731-31205A70-CE2C-4499-B90A-306740F4567E

Q24294731-74A8FAC0-4AFA-4067-9400-19C65EF19E7D

Q24294731-767E9313-2298-48EE-8DD6-4AE949E3F037

Q24294731-8675575E-54B9-49FA-8948-4F3C845B7771

Q24294731-A30E561C-ED28-4F77-836B-257BE6D4F0AF

Q24294731-A8B09061-079E-4C92-9AE6-CE0706706CA6

Q24294731-B0ED2DAC-AA2F-44AE-AA8B-8268A3C736E5

Q24294731-C09ED668-4F5E-4B4A-9AF0-74897C37C2B2

Q24294731-C54C11B5-F495-400D-80ED-0604BB7CA2F2

P2888

Q24294731-5AAFFA3F-A8D5-48EE-9FB6-9C3B1C003606

P304

Q24294731-80947077-AFF0-46EC-8A1B-9992DBF5C1C4

P31

Q24294731-42EE6AF5-6F70-40DA-8A6D-158BCEB9CEF5

P356

Q24294731-C2CC2421-C2FA-4372-BACD-EBA83A3C8E3D

P407

Q24294731-5F663B63-00AF-4A4A-A3E3-3A48AD927B12

P433

Q24294731-521E04F5-4BF5-453E-BB0D-C986956972B4

P478

Q24294731-26654573-9324-4EE4-90ED-7BC1007A8C3C

P577

Q24294731-D4B62C6C-4985-40AC-9507-2EC6A76EF2CB

P6179

Q24294731-B73C9C39-7FD6-4D3A-9B3D-745E5634128A

P698

Q24294731-0FA8B667-D763-4C14-9595-4B7B0850583B

P921

Q24294731-7B4CADEF-E144-490C-B5EC-C397F81F1AEA

Q24294731-8F8BE789-184B-4CDB-BEDA-3514154DD504

Q24294731-ddc0a3e3-6503-43c9-9c90-431832a19f26

P356

P1433

P1476

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

@en

P2093

A Sommer

http://www.w3.org/2001/XMLSchema#string

C H Hannum

http://www.w3.org/2001/XMLSchema#string

C J Wilcox

http://www.w3.org/2001/XMLSchema#string

D J Dripps

http://www.w3.org/2001/XMLSchema#string

F G Joslin

http://www.w3.org/2001/XMLSchema#string

L G Armes

http://www.w3.org/2001/XMLSchema#string

P L Heimdal

http://www.w3.org/2001/XMLSchema#string

R C Thompson

http://www.w3.org/2001/XMLSchema#string

S P Eisenberg

http://www.w3.org/2001/XMLSchema#string

W P Arend

http://www.w3.org/2001/XMLSchema#string

P2888

P304

336-40

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/343336A0

http://www.w3.org/2001/XMLSchema#string

P407

P433

6256

http://www.w3.org/2001/XMLSchema#string

P478

343

http://www.w3.org/2001/XMLSchema#string

P577

1990-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1030451293

http://www.w3.org/2001/XMLSchema#string

P698

2137200

http://www.w3.org/2001/XMLSchema#string

P921

negative regulation of interleukin-1-mediated signaling pathway

Interleukin 1 receptor antagonist